http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-66524-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate | 1991-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c187050e952d66c07bd2be64a57bfa72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e508e766f6ef0ebe2ae9d50fdac8b5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4702552d16943176786b7ec257cce8 |
| publicationDate | 1996-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-66524-B1 |
| titleOfInvention | A process for the preparation of peptides by solid-phase synthesis |
| abstract | A process for the production of peptides of the formula (X)n-A-NH2 in which X is a natural or unnatural amino acid, azaamino acid or imino acid, n is an integer from 1 to 50, preferably 1 to 30, and A is an azaamino acid, and the physiologically tolerated salts thereof is described and is characterised in that a spacer is converted into a form which can be acylated, and the latter is reacted with a suitable formic acid derivative and subsequently with an appropriate amino acid hydrazide, where appropriate the protective group is converted into a protective group which is base-labile or labile to weak acids, the spacer obtained in this way is coupled to a resin, the required peptide is built up stepwise from the C-terminal end, and subsequently the peptide is cleaved off the resin and, where appropriate, converted into its physiologically tolerated salts. |
| priorityDate | 1990-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.